European Journal of Oncology Nursing 50 (2021) 101861

Contents lists available at ScienceDirect

European Journal of Oncology Nursing

journal homepage: www.elsevier.com/locate/ejon

Understanding the support needs of family members of people undergoing

chemotherapy: A longitudinal qualitative study
Emma Ream a, *, Alison Richardson c, Grace Lucas b, Afrodita Marcu a, Rebecca Foster c,
Ginny Fuller 1, Catherine Oakley d
a
University of Surrey, Guildford, UK
b
City University, London, UK
c
University of Southampton, Southampton, UK
d
Guy’s and St Thomas’ NHS Foundation Trust, London, UK

A R T I C L E I N F O A B S T R A C T

Keywords: Purpose: Capture change in family members’ experiences as they look after patients during chemotherapy, and
Cancer understand variability in their needs for support.
Chemotherapy Method: Longitudinal digitally-recorded qualitative semi-structured interviews with family carers at the begin­
Family carers
ning, mid-point, and end of treatment. Twenty-five family members (17 women, 8 men), mean age 53, were
Longitudinal
Qualitative
interviewed. Fifteen participants were supporting a relative having chemotherapy with curative intent, and 10 a
Support needs patient receiving palliative chemotherapy. They were recruited from two UK locations: a regional cancer centre
in Southampton and a comprehensive cancer centre in London. Sixty-three interviews were conducted in total,
and the data were analysed using Framework Analysis.
Results: Three themes were generated from the data: Changing lives, Changing roles; Confidence in caring, and
Managing uncertainty. These captured family carers’ evolving needs and sense of confidence in caregiving during
chemotherapy. Carers reported considerable anxiety at the outset of treatment which persisted throughout.
Anxiety was underpinned by fears of disease recurrence or progression and concerns about treatment outcomes.
Conclusions: This study presents original fine-grained work that captures the changes over time in family carers’
experiences of chemotherapy and their adaptation to caregiving. It provides fundamental evidence of the
challenges that cancer carers face during patients’ treatment; evidence that can be used as a basis for carer
assessment and to build much-needed carer interventions. Oncology nurses should assess carers’: ability to care;
needs for information and support to prepare them for this; wellbeing over time; and, any support they may
require to prevent them from becoming overburdened.

1. Introduction physical support, assist with symptom management, help administer

medicines and coordinate care (Ullgren et al., 2018).
A cancer diagnosis profoundly affects both patients and their family Supporting someone through cancer comes at a cost. Carers can
and friends. In the United Kingdom, over 360,000 people are diagnosed experience extreme strain, anxiety and distress (Grimm et al., 2000;
with cancer annually (Cancer Research UK, 2018), and about 1.5 million Aranda and Hayman-White, 2001; Matthews et al., 2003; Deshields
people provide informal care for them (Macmillan Cancer Support, et al., 2012; Lambert et al., 2016). This is particularly pronounced
2016). Informal carers - people including family and friends who give during chemotherapy (Renovanz et al., 2018), a treatment associated
unpaid support to people with cancer - adopt a number of roles. During with toxicities that can prove life-threatening at worst (NCEPOD, 2008)
chemotherapy, these roles include being an advocate, companion, pro­ and impact quality of life at best. It evokes considerable fear (Bell, 2009;
tector and practical caregiver (McIlfatrick et al., 2006; Ream et al., Hofman et al., 2004) in patients and carers and their anxiety is com­
2013). Further, carers provide patients with significant emotional and pounded by chemotherapy typically being provided in outpatient

* Corresponding author.
E-mail addresses: e.ream@surrey.ac.uk (E. Ream), afrodita.marcu@gmail.com (A. Marcu).
1
Independent

https://doi.org/10.1016/j.ejon.2020.101861
Received 6 November 2019; Received in revised form 16 October 2020; Accepted 19 October 2020
Available online 11 November 2020
1462-3889/© 2020 Published by Elsevier Ltd.
E. Ream et al. European Journal of Oncology Nursing 50 (2021) 101861

settings. This requires them to monitor and manage side-effects at home first ever course of chemotherapy; and without any cognitive impedi­
(McIlfatrick et al., 2006; McKenzie et al., 2017; Ullgren et al., 2018). ment. Eligible carers were: family members nominated by patients as
Carers report that their needs for information and support are often providing most support; over 18 years; able to communicate in English;
overlooked by healthcare professionals (Ussher et al., 2009) and and able to comply with the research protocol.
consequently go unmet (Sklenarova et al., 2015). They report low Twenty-five participants were sought. This sample size reflects rec­
self-efficacy in providing care, insecurity around both managing ommendations that qualitative researchers interview fewer than 50 in­
chemotherapy side-effects and recognising changes in patients’ health terviewees (Ritchie and Lewis, 2003) in order to maintain quality of data
(Williams et al., 2013) and concerns over ensuring patients’ safety collection and allow in-depth analysis. Further, it is suggested that
during chemotherapy (Applebaum and Breitbart, 2013). limited new information is revealed when more than 25–30 participants
Through developing a fine-grained understanding of carers’ needs are interviewed (Hennink et al., 2017). In this study, the research teams
for support during cancer treatment, healthcare professionals can in Southampton and London reviewed collectively the data every two
develop, evaluate and implement pertinent interventions to alleviate weeks to establish the point at which no new information was being
carer distress and enhance their caregiving capacity. While a number of generated - information that would either enhance or alter the study
studies have reported on carers’ support needs during chemotherapy findings – indicating that data saturation had been achieved and data
(McIlfatrick et al., 2006; Ream et al., 2013; Norton et al., 2019), few collection could cease. Data saturation was achieved at each time point
have examined these over time; a perspective that would give insight despite fewer interviews being conducted over time (see findings).
into how carers’ support needs and confidence in caregiving change as To capture a broad range of experiences relating to caring for a
treatment unfolds. Some studies have used a longitudinal approach family member through chemotherapy, carers were selected purposively
when exploring cancer carers’ experience more generally (Murray et al., according to: treatment intent (curative/palliative); age (younger/older
2010; Girgis et al., 2013; Walshe et al., 2017; Roberts et al., 2018) but than retirement age); gender and, relationship to the patient (spouse/
the challenges faced by carers during chemotherapy have not featured. partner and other relationships).
Few interventions have been developed to address carer needs during
chemotherapy (e.g. Tsianakas et al., 2015). 2.3. Qualitative interviews
We sought to address the evidence gap by undertaking a longitudinal
qualitative study to describe carers’ experiences whilst supporting rel­ The study was approved by the North London REC3 (now London-
atives through chemotherapy and to explore how their support needs Harrow NHS Ethics Committee) REC Ref: 11/H0709/2. The first inter­
and caregiving confidence evolved during treatment. We focused on the view (T1) asked about: perceptions and expectations of chemotherapy;
needs of family members as they predominantly – over friends – provide changes to everyday life that had been introduced; information and
this support. We purposively sampled family members of people having support needed; and that provided by healthcare professionals. The
either curative or palliative treatments in order to gain understanding of second (T2) focused on: status of work and other commitments since
how this context may impact experience. Such inquiry has not been previous interview; symptoms, side-effects and unplanned for events (e.
undertaken to date. g. hospitalisation) experienced by their relative; help-seeking under­
taken; experience of caring; feelings of confidence and competence in
2. Methods caring; needs for information and support and level to which they were
met. The final interview (T3) was similar to T2 except it additionally
2.1. Design discussed carers’ experiences of chemotherapy in relation to their ex­
pectations at the start.
A longitudinal qualitative design was adopted, entailing digitally- Interviews were undertaken by two researchers (JF-J and RF), varied
recorded semi-structured interviews conducted with family carers at in length from 11 min to 1.5 h, were recorded digitally and were pro­
three points during patients’ treatment with intravenous chemotherapy: fessionally transcribed. They were undertaken in a venue of carers’
start of treatment (T1), mid-point (T2) i.e. point where half of the choice: 18 were undertaken in carers’ private homes; 19, over the
planned cycles of chemotherapy had been administered, and completion telephone; 23, within the hospital setting, and 3, at the carers’
of chemotherapy (T3). Interviews focused on carers’ need for informa­ workplace.
tion and support from healthcare professionals and factors that affect
their confidence and competence in caring for someone over the course 2.4. Data analysis
of chemotherapy. Analysis of longitudinal data can provide rich un­
derstandings of changes and/or stability over time, factors that may Interview data were analysed using Framework Analysis (Ritchie and
account for these, and both how and why experiences may vary between Lewis, 2003), a matrix-based approach for collating, reviewing and
individuals (Saldaña, 2003; Calman et al., 2013). understanding qualitative data-suitable for analysing longitudinal data
(Ritchie and Lewis, 2003). A thematic coding framework was devised
2.2. Participants from recurrent themes within the data (RF, JFJ, ER) and applied across
transcribed accounts (RF, JFJ). Coded data were transferred to a matrix
We specifically sought carers of people having combination chemo­ that allowed data from each of the interviewees’ three interviews to be
therapy treatments incorporating cisplatin; these treatments produce integrated (rather than analysing each set of interviews independently).
significant toxicity and, it was envisaged, would give insight into how Matrices incorporated both narrative summary and relevant quotes in
carers would help with managing difficult side-effects. Carers were accordance with the Framework Analysis approach (see Fig. 1a).
identified by patients and recruited from a comprehensive cancer centre The data were analysed both cross-sectionally through construction
in London and a regional cancer centre in Southampton, in the south of of matrices (Fig. 1a), and longitudinally (Calman et al., 2013) through
England, between April 2011 and May 2012. Patients new to chemo­ mapping individuals’ data over the three time periods (Fig. 1b). These
therapy were screened for eligibility by the clinical team and processes enabled identification of both convergent and divergent ex­
approached for consent to recruit the family member they considered periences between carers at each time point and the capture of
their principal provider of care. Patients were usually approached when within-individual dynamics. It was possible to identify changes in ex­
they attended a pre-treatment consultation. Eligible patients were: periences and perceptions over time, both within and across individuals,
receiving cisplatin-based chemotherapy for gynaecological, lung, to explore how these arose and to posit some explanations for them. Data
testicular or colorectal cancer; over 18 years; willing for their family analysis commenced as data were generated and was iterative; the re­
member to be approached; able to communicate in English; having their searchers moved back and forth in a systematic manner between

2
E. Ream et al. European Journal of Oncology Nursing 50 (2021) 101861

Fig. 1. Extracts depicting data analysis process. 1a: Example of matrix used in longitudinal analysis: Combining working and caring responsibilities.1b: Example of
mapping over time for Carer P1

generating interview data and analysing them thus allowing areas of was 53 years; most were a spouse/partner (n = 19). Fifteen carers were
questioning to develop as understanding of an area grew or additional supporting a patient having curative chemotherapy (marked ‘C’ before
clarity was sought. the participant’s number). The remainder supported patients having
palliative chemotherapy (marked ‘P’) (see Tables 1 and 2 for partici­
3. Findings pants’ details).
Data analysis identified three themes that which reflected carers’
One hundred and one patients were screened for eligibility and 64 experiences and support needs over time: Changing lives, Changing roles;
eligible carers were approached about the study in order to consent 25 Confidence in caring, and Managing uncertainty. These themes endured
carers as planned. Five carers withdrew before the second interview, and over time but some aspects of them – sub-themes – varied as treatment
a further two before the third. Withdrawals followed deterioration in progressed and patients’ needs altered. Some appeared linear with
patients’ health or their death (see Fig. 2). trends (either improvement or decline) over time, whilst others had no
Seventeen female and 8 male carers were recruited, their average age evident pattern. Some differences in carer experience were evident

3
E. Ream et al. European Journal of Oncology Nursing 50 (2021) 101861

Fig. 1. (continued).

according to the intent of patients’ treatment (curative versus palliative) going because you do. But when he’s home and he’s just laid there, you doing
(see Table 3). everything, you’re tidying up, you’re doing the kitchen, you cutting the grass
and he’s just sat there and you think you know he can’t, but at the same time
you [think], lazy git. (C5, F, 44, partner).
3.1. Changing lives, changing roles It was clear that the stress felt by carers, created by caregiving during
chemotherapy, did not abate with time. A high level of unremitting
The first theme indicates how, across time, carers’ lives changed as stress, that commenced when chemotherapy started, was felt by all
did the roles they undertook in supporting patients. Carers found that carers. The burden of helping to manage patients’ treatment and the
they rapidly (from T1) had to undertake more roles within the home as associated disruption to carers’ lives appeared to increase with time.
many relatives’ felt the immediate effects of treatment. These obliga­
tions grew with time (T2 and 3) and many carers felt accompanying 3.1.2. Impact on our interactions
stress. The changing domestic dynamic appeared to have a knock-on Carers accounts made it evident that relationships between carers
effect that was felt more keenly over time (by T2 and T3) on relation­ and patients often changed over the course of chemotherapy; for some
ships with some becoming stronger and others frayed. Concerns over relationships improved, whilst for others they declined. By treatment
financial stability were constant (present from T1 and persisting to T3) mid-point, carers’ everyday roles had changed – many had to undertake
and influenced by working carers’ decisions to decrease (due to care­ additional household chores and were instrumental in ensuring patients
giving requirements) or increase (due to financial need) employment as attended appointments, took medications and attained help from clin­
needed. A balance was evident for those of working age – between ical teams if they become unwell. While for some patient-carer dyads,
caregiving and working - that was challenging for some to achieve. this changed dynamic within relationships and the home helped to make
bonds between them stronger, others found relationships became
3.1.1. You doing everything strained:
At the start of treatment, carers described how their lives had been It would be easy for me to feel that she doesn’t always appreciate what I
disrupted by the patient’s cancer diagnosis and the many new roles that do for her but there again you can’t expect people to be continually grateful
they undertook in caring for their relative. They were willing to provide for what you’re doing … Just occasionally, erm, she’ll be feeling so fed up
care and wanted to help, but the impact was immediate: that, erm … that does impact on our interactions. (P10, 78, M, husband).
Well, every day after work I have to come over here or I meet my mum and The impact of treatment on personal connections extended to
we go to treatment. Or whatever days I’m off I’m over here, cleaning the broader relationships. Some carers felt distanced from family members
house, cooking and washing clothes and make everything sterile and make and friends and unable to engage in everyday social roles through
sure everything’s clean so that she doesn’t get an infection … I live on my own needing to be at home. They described feeling ‘isolated’ and struggling
so it’s like living two lives. (C4, F, 28, daughter). to commit to arrangements (P5, 35, M, fiancé). In contrast, other carers,
By the second interview, a pronounced sense of chemotherapy taking particularly those caring for a relative having palliative chemotherapy,
over carers’ lives was evident as caregiving roles began outstripping reported feeling closer to, and very supported by, other members of their
other social roles and caregiving became ‘a job in itself’. Carers not used family. One man caring for his wife with mesothelioma described how
to housework, or caring in a physical capacity, felt an acute sense of his bond with his sons had strengthened:
strain. Some carers of people having curative treatment struggled with My two boys now, we now go out every two or three weeks on a Saturday.
the ongoing burden of caregiving and voiced some growing frustration We have lunch and then we have a few beers, which we never used to and I
and resentment: think this is all because they are looking out for me. […] We never used to do
Yeah still doing it all but resentments kicked in. I don’t know if I said that it on a regular basis it’s about time we did, life’s too short, as I said, and now
last time, I think it’s just a recent thing. Because when he was in hospital I kept

4
E. Ream et al. European Journal of Oncology Nursing 50 (2021) 101861

Fig. 2. Flow of participants through the study.

we do that. (P7, M, 68, husband). patients at appointments or though periods of acute illness. However,
Thus, although there was a trend over time for carers’ relationships others had to take unpaid leave or holiday to cover caregiving re­
to be altered, these could become either fractured or enhanced during sponsibilities, making their support of patients harder to manage.
chemotherapy according to individual circumstance. Further, this could Carers’ concerns over remaining in employment, and earning suffi­
apply to relationships with not only with the patient but also with their ciently to support their needs, were unabating over the course of their
wider family, friendships and social groups. relatives’ treatment. Indeed, by the third interview, the need to work
reduced the level of support some carers could offer patients, e.g. some
3.1.3. I’m the breadwinner needed other family members or friends to attend patients’ treatment in
Thirteen carers were in employment at some point during data their place. Carers’ work commitments were often driven by reduced
collection. At first interview, they reported challenges with balancing financial circumstances due to patients’ inability to work.
demands of caring with those of work:
I’m the breadwinner at the moment and I need to keep that going so it is 3.2. Confidence in caring
difficult. Mentally, I can cope when I haven’t got to do the work-side and just
concentrate on him and the house. (C5, F, 44, partner). The second theme reflects carers’ confidence in supporting their
Concerns over financial stability were clear from the outset for most relative through chemotherapy and managing the side-effects associated
carers. Their anxieties were compounded or lessened according to em­ with it. Three sub-themes were evident that showed how carers collec­
ployers’ attitudes and practices. Some carers reported having flexible tively progressed from: trepidation over side-effects and uncertainty
and understanding employers who allowed them time off to support about when and how to seek help for them (T1); to growing confidence

5
E. Ream et al. European Journal of Oncology Nursing 50 (2021) 101861

Table 1 3.2.2. You know what to look out for

Characteristics of carers recruited to the study. By treatment mid-point, carers felt more confident in recognising
Age Mean 52.6 (range 18–78) severe symptoms and had a better understanding of when help-seeking
for them was warranted:
N %
Gender 17 68 I think as its gone on, you just know what to look out for and you kind of
Female 8 32 get a feel for what’s a problem and what isn’t too much of an issue, and just
Male getting used to it, I think. (C11, 27, F, girlfriend).
Relationship to patient 19 76 However, as at T1, they believed it essential to have direct access to
Spouse/partner 5 20
Daughter 1 4
healthcare professionals when required in order to continue building
Mother and maintaining confidence in caregiving. Carers felt more confident in
Patients’ cancer diagnosis 11 44 caregiving when they received prompt help from healthcare pro­
Lung 6 24 fessionals, and when they trusted their acute oncology service. Where
Colorectal 3 12
help-seeking had proved difficult early in the treatment trajectory,
Cervical 2 8
Testicular 2 8 carers remained concerned over monitoring and managing acute treat­
Ovarian 1 4 ment toxicities.
Endometrial
Intent of treatment 15 60 3.2.3. Doing it all the time
Curative 10 40
Palliative
By the end of treatment, most carers reported feeling confident in
Length of treatment 10 40 their ability to support their relative through chemotherapy and its
>4 months 9 36 associated side-effects. This reflected their familiarity through ‘doing it
2–4 months 6 24 [caregiving] all the time’. However, when new - or less tangible -
<2 months
symptoms arose e.g. fatigue or weakness, carers reported feeling unsure
of how best to help. This undermined some carers’ confidence in their
in recognising and addressing important side-effects (T2); to, the care­ ability to resolve issues and concerns. They also perceived that their
giving process becoming routine or second-nature (T3). confidence in caregiving was enhanced through establishing trusting
relationships with healthcare professionals:
3.2.1. We weren’t sure if it was a problem I got more confident because I knew what I was doing, I knew where I was
During the first interview, carers expressed trepidation over moni­ going. The people were recognisable, they all recognised [patient] and, you
toring chemotherapy side-effects. Some felt well-prepared – buoyed by know, if I had any problems I felt that they were friendly enough and easy
the assumption that they would have easy access to healthcare pro­ approachable, not sort of someone that I would find intimidating or anything.
fessionals to convey ‘look, this is happening, or, I can’t do this, or so on I could just go up to them and sort of say … no matter if it was a little thing
and so forth. Help!’ (P7, 68, M, husband). In practice, this contact and that, you know, oh we’ve been feeling like this, is this normal? (C8, 51, F,
reassurance was not always forthcoming. One carer explained how she mother).
could not access help over the weekend, while others found it chal­ Whilst time and experience increased carers’ confidence in managing
lenging to decide what constituted an ‘urgent’ concern: side-effects and in gaining help when it was needed, some carers
… you can page a registrar if it’s urgent but we weren’t sure if it was a retained elements of uncertainty and felt strong need for ongoing
problem or if it was urgent, so that was probably the most stressful thing, not guidance from healthcare professionals.
knowing whether you should phone them in the middle of … it was only like
11pm but whether just to … so we just waited until the morning. (C11, 27, F,
girlfriend).

Table 2
Details of the individual carers.
Carer ID Carer age Carer gender Relationship to patient Patient’s diagnosis Intent of treatment Length of treatment

P1 51 Female Wife Lung Palliative >2–4 months

P2 35 Female Wife Lung Palliative >2–4 months
P3 54 Female Daughter Lung Palliative >2–4 months
P4 65 Female Wife Lung Palliative >2–4 months
P5 35 Male Fiancé Colorectal Palliative >2–4 months
P6 60 Female Wife Colorectal Palliative >4 months
P7 68 Male Husband Mesothelioma Palliative >4 months
P8 33 Female Daughter Mesothelioma Palliative >4 months
P9 67 Female Wife Lung Palliative <2 months
P10 78 Male Husband Ovarian Palliative >2–4 months
C1 75 Male Husband Lung Curative <2 months
C2 60 Female Wife Lung Curative >4 months
C3 63 Male Husband Colorectal Curative >2–4 months
C4 28 Female Daughter Cervical Curative <2 months
C5 44 Female Partner Lung Curative <2 months
C6 29 Female Wife Testicular Curative >2–4 months
C7 65 Female Wife Colorectal Curative >4 months
C8 51 Female Mother Testicular Curative >2–4 months
C9 25 Female Daughter Lung Curative <2 months
C10 71 Male Husband Cervical Curative >4 months
C11 27 Female Girlfriend Colorectal Curative >4 months
C12 78 Male Husband Ovarian Curative >4 months
C13 66 Female Wife Colorectal Curative >4 months
C14 70 Male Husband Endometrial Curative >4 months
C15 18 Female Daughter Cervical Curative <2 months

6
E. Ream et al. European Journal of Oncology Nursing 50 (2021) 101861

Table 3 unpleasant side-effects and risks of chemotherapy without attaining the

Change in carers’ needs and experiences over time. intended remission from disease. Three carers of people having curative
Constant Fluctuating; no Increasing chemotherapy reported physical complaints at T1 which they related to
evident pattern with time stress.
Theme 1: Changing lives, Changing roles Carers of people having palliative chemotherapy expressed less
Changed role at home, burden of * anxiety at the start of treatment, as they ‘just had to deal with it’ (P8, F,
responsibility (Subtheme: You 33, daughter). They articulated acceptance and viewed treatment as
do everything) offering hope whilst acknowledging that death might be inevitable.
Stress & worry over maintaining *
work and/or duties in the home
Carers’ desire for information about prognosis varied: information hel­
& caring responsibility ped some manage uncertainty – they wanted to know ‘what to expect’
(Subtheme: You do everything) (P7, M, 68, husband), whilst others felt strongly that they did not want to
Impact on relationships; either * know more. One explained ‘when we saw the oncology specialist at X
strengthened or strained
hospital well she went into so much detail, and we thought why do we need all
(Subtheme: Impact on
interactions) this detail, you know’ (C12, M, 78, husband).
Financial worries (Subtheme: I’m *
the breadwinner) 3.3.2. Taking control
Theme 2: Confidence in Caring By treatment mid-point, carers voiced how routines of treatment –
Need for health care professional *
input, support & information
and the familiarity of associated symptom patterns – reduced uncer­
(Subtheme: We weren’t sure it tainty. Although caregiving and the demands of patients’ treatment
was a problem) remained unremitting, knowledge of what was happening provided a
Confidence in accessing help & * sense of control:
identifying problems
I know what the routine is and I expect him to be slightly more poorly in
(Subtheme: You know what to
look out for; Doing it all the time) his full week than the week that he is doing one day. So I think, you come to
Challenges with new symptoms * terms with it … I mean, it’s become like a routine now. I know what’s ex­
and situations (Subtheme: We pected. I know it’s going to take 5 h and I try to manage my time … it’s
weren’t sure it was a problem) become a bit more … not easier, but it’s become a bit more routine because I
Theme 3: Managing Uncertainty
know what to do now. (C8, 51, F, mother).
Fear about recurrence or spread *
(Curative patients) (Subtheme: However, this was not the same for everyone – for some, the side-
Steel myself for anything) effect patterns (with marked peaks and troughs) stimulated pre-
Worries about patient’s decline * emptive worry over future cycles of treatments and potential difficulties.
and end of life (Palliative
Many carers of people having palliative treatment reported that side-
patients) (Subtheme: How do we
get to the other side?) effects were fewer than anticipated and they talked positively (as they
Belief that treatment offers hope * had at T1) about the ‘glimmer of hope’ (P8, 33, F, daughter), sense of
(Palliative patients) (Subtheme: ‘momentum’ and ‘taking control’ that treatment provided (P3, 54, F,
Steel myself for anything) daughter). However, for some, fears about how they would manage if
Needs for information *
the patients’ health declined had turned to ‘dark moments’ and ‘anger’
(Subthemes: Steel myself for
anything; Taking control) (P7, M, 68, husband).
Anxiety and stress (Subthemes: * In contrast, carers of people having curative treatment voiced a sense
Steel myself for anything; How do of the journey peaking, with side-effects taking longer to subside and
we get to the other side?)
their own energy running low. These carers reflected on a new normality
shaped by cancer and its treatment, and their reflections were tinged
3.3. Managing uncertainty with anxiety when they (often erroneously) interpreted side-effects as
signs of cancer spreading.
This theme reflects the manner in which carers experienced uncer­
tainty across the course of patients’ chemotherapy with them expressing 3.3.3. How do we get to the other side?
trepidation at first (T1) and associated anxiety. Thereafter, they referred The final interview provided a chance for carers to reflect. For carers
to the benefits of routine as they adjusted to the ‘new normal’ of living of people having palliative chemotherapy, there was a sense that
through chemotherapy and of feeling more in control (T2). Towards the chemotherapy had been ‘a lot less scary’ than initially feared (P8, F, 33,
end of treatment (T3) carers were reflective and voiced new concerns, daughter). However, the end of treatment also heralded feelings of
renewed anxiety and increased trepidation as treatment ended. There anxiety for them; concerns remained over how patients could deterio­
appeared some differences according to whether patients’ treatment was rate and how they would cope as end of life neared. For carers of people
either curative or palliative. having curative chemotherapy, anxiety and stress appeared cumulative.
Carers spoke of the need to transition to ‘the other side’ of treatment as
3.3.1. Steel myself for anything they contemplated what might happen next:
As treatment started, carers voiced concerns about the future, … now everything’s over it’s actually, oh my god, we’ve just done all that
notably about treatment side-effects that they were anticipating. For and we’ve survived [to] the other side, because before we started I said to
carers of people having curative chemotherapy, uncertainties became [patient] how do we get to the other side when we get there?’ (C5, 44, F,
more pronounced as the reality of treatment set in and anxieties man­ partner)
ifested about how their relatives would manage:
Well I thought to myself well I’d better steel myself for anything here As one carer articulated, her worries were ‘always going to be there’
because I don’t know how it’s going to affect her every day, and I was getting in the future as monitoring and check-ups continued (C8, F, 51, mother).
a bit concerned about whether she would be able to, would she be in a state to After the routine of treatment and structure of appointments, there
be at home on her own if I was working. (C3, M, 63, husband). emerged a return to uncertainty – as one participant explained, there
For some, concerns over disease recurrence appeared at the root of was an acute sense of uncertainty over ‘what does the future hold?’ (P8,
their anxieties; they were concerned that their relative would undergo 33, F, daughter).

7
E. Ream et al. European Journal of Oncology Nursing 50 (2021) 101861

4. Discussion recurrence and this concept is relatively well-researched (Armes et al.,

2009); however, the nature of fear of recurrence and/or progression
This is a first study of its kind to describe the experiences over time of held by carers is much less researched, with few exceptions (Hodges and
carers supporting family members through chemotherapy, and to detail Humphris, 2009).
how their needs for support and their confidence in providing care Our research suggests that it is important for healthcare professionals
change over the course of treatment. Further, it allowed comparison to: i) appreciate differing perspectives held by carers towards chemo­
between the experiences of carers according to whether their relatives therapy according to patients’ prognosis and treatment intent; ii) un­
were being administered curative or palliative treatment. The study’s derstand how carers’ ability to provide care and associated burdens of
longitudinal qualitative design captured the changes over time in carers’ caring are affected by both patient need and their own capacity to care;
experiences and identified how they could vary according to patients’ iii) recognise the challenge for carers on transition to life following
disease status, treatment intent and individual circumstance. chemotherapy, and iv) develop and institute appropriate supportive
Across the sample, there was a sense that carers – whilst willing to interventions for carers that can accommodate their changing experi­
support their relatives through chemotherapy – sometimes felt over­ ence and need.
whelmed by the burden of patients’ illness and its associated treatment. It is important to note that our research focused solely on people that
Past research has established that treatment itself is burdensome and can had carers; not every person with cancer has a family member or friend
disrupt patients’ daily lives, decrease their desire to follow onerous and to look after, and support, them through chemotherapy. It is important
complex treatment schedules and diminish patients’ overall quality of that the experiences of people without carers to call upon are understood
life (May et al., 2009). We argue that these burdens are experienced as as these patients are likely to find the rigours and burdens of treatment
much by carers as patients. Indeed, previous literature suggests that harder to contend with than their counterparts with carers. Interest­
cancer carers can be profoundly affected during patients’ chemotherapy ingly, this group has been the subject of little research to date.
(Grunfeld et al., 2006; Jenewein et al., 2008). Carers report that the
changes to everyday lives, required to support someone through 4.1. Strengths and limitations of the study
chemotherapy, are challenging to adapt to (McIlfatrick et al., 2006;
McKenzie et al., 2017; Schmer et al., 2008). This study identified that One strength of this study lies in its longitudinal qualitative design
carers in employment – particularly those struggling to meet work which enabled carers’ experiences to be captured along the treatment
commitments – are particularly vulnerable to burden and distress. Given trajectory, advancing much needed conceptualization of their experi­
that around 50% of carers are in employment (Kent et al., 2019), there is ences (Fletcher et al., 2012) and their adjustment to their role. Whilst a
a sizeable population whose vulnerability and needs during patients’ few other studies (e.g. Taylor et al., 2016) have taken a longitudinal
chemotherapy need to be assessed and addressed. Further, this study qualitative approach to explore carers’ experiences during patients’
ascertained that many work-related stressors arise at the start of treat­ treatment for cancer, they have not specifically focused on how carers’
ment suggesting that healthcare professionals need to be proactive at experiences vary during chemotherapy – a particularly challenging form
this time, as well as revisiting issues related to work later on. of treatment that can pose high risk to patients.
The importance to carers of having easy and quick access to health The main limitation to the study lies in the fact that the findings
professionals to consult if their relative becomes unwell was evident in represent only some carers’ experiences. From 64 eligible carers
this study. However, rapid and straightforward access was not experi­ approached about the study, around 60% (of either patients or their
enced by all carers. This was particularly problematic if lack of support carers) declined participation as they felt that they had too much to deal
was encountered early in treatment - when carers had uncertainties over with without taking part. Arguably, the carers and patients who declined
what to expect or how to go about help-seeking. Challenges with participation may have had more acute needs and/or more diverse ex­
consulting with professionals will arguably contribute to the isolation, periences than the ones who participated.
fear and low confidence in caregiving that some carers report (Ream Additionally, it was not possible to comment on the experience over
et al., 2013). Further these feelings are liable to increase any anxiety and time of those who withdrew between the first and last interview. These
depression; levels of anxiety in carers can be higher than those experi­ carers withdrew because either their relatives’ health had declined or
enced by patients and endure for at least five years following patients’ they had died.
diagnosis (Girgis et al., 2013). The majority of those interviewed were the patients’ partner or
This study is one of only a few to investigate carers’ experiences and spouse. However, these carers intimated during their interviews, that
needs over time. Previous work that has identified identified carers’ wider family members were affected by their relatives’ chemotherapy
roles and contributions during chemotherapy (e.g. McIlfatrick et al., and were also involved in – and affected by - caregiving. These carers
2006) has reported this in a somewhat static fashion, failing to highlight were not represented within our sample. The complexity of situations
the dynamic nature of carers’ caregiving contribution. Further, this involving multiple carers warrants further investigation.
study depicted how carers’ confidence in caregiving grew as treatment Another potential limitation to the study relates to the fact that we
progressed as long as they could access appropriate help when needed. recruited only carers of people being treated with cisplatin-based
With the advent of acute oncology services, the challenge for patients treatments; treatments known to have significant toxicity. It is
and carers of gaining quick access to oncology professionals when possible that carers looking after patients receiving different chemo­
needed has largely lessened (Neville-Webbe et al., 2013). therapy treatments may have had different experiences from those
It was also noteworthy how the outlook and perceptions of chemo­ captured in this study.
therapy held by our study participants – as either a treatment to be
feared or one offering hope – differed according to whether chemo­ 5. Conclusions
therapy was being given to prevent recurrence or as a palliative mea­
sure. Additionally, carers’ views on transition to life post-chemotherapy Chemotherapy is – and will remain – an important treatment for
varied markedly although all were characterised by uncertainty, at cancer for the foreseeable future and will continue to be delivered pri­
marked odds to feelings of control generated by the routine of treatment. marily in day care settings. This requires carers to take considerable
For carers of people having curative treatment, fear of recurrence was responsibility for patient wellbeing at home. Carers play an important
evident. For those caring for people completing palliative treatment, role in patient safety – recognising and responding to symptoms and
uncertainties predominantly centred around the length of time before knowing when to access help for acute toxicities which can lead to
disease would progress and their – and patients’ – likely resilience as end sudden patient deterioration. It is essential that healthcare professionals
of life neared. The literature increasingly refers to patients’ fear of prepare carers and ensure that they are well equipped for, and supported

8
E. Ream et al. European Journal of Oncology Nursing 50 (2021) 101861

in, caregiving; this will help to safeguard patient safety. Carers’ input Cancer Research UK, 2018. Cancer Statistics for the UK. Retrieved from. http://www.
cancerresearchuk.org/health-professional/cancer-statistics-for-the-uk.
enables healthcare services to operate and contributes substantially to
Deshields, T.L., Rihanek, A., Potter, P., Zhang, Q., Kuhrik, M., Kuhrik, N., O’Neill, J.,
cost reduction at the end of life (Round et al., 2015) as patients and 2012. Psychosocial aspects of caregiving: perceptions of cancer patients and family
clinicians rely on carers’ support and care management skills (McKenzie caregivers. Support. Care Canc. 20 (2), 349–356.
et al., 2017). This study suggests that some carers are at risk of becoming Fletcher, B.S., Miaskowski, C., Given, B., Schumacher, K., 2012. The cancer family
caregiving experience: an updated and expanded conceptual model. Eur. J. Oncol.
overburdened by requirements imposed by patients’ illness, fear for the Nurs. 16 (4), 387–398. https://doi.org/10.1016/j.ejon.2011.09.001.
future and requirements of treatment. However, conversely carers can Girgis, A., Lambert, S.D., McElduff, P., Bonevski, B., Lecathelinais, C., Boyes, A.,
be very positive, upbeat and manage caring without detriment to their Stacey, F., 2013. Some things change, some things stay the same: a longitudinal
analysis of cancer caregivers’ unmet supportive care needs. Psycho Oncol. 22 (7),
own wellbeing. Thus, it is important that they have their caring ability 1557–1564. https://doi.org/10.1002/pon.3166.
and needs assessed, particularly as they may be reluctant to ask for Grimm, P.M., Zawacki, K.L., Mock, V., Krumm, S., Frink, B.B., 2000. Caregiver responses
support (Renovanz et al., 2018). The demands on them – and their needs and needs: an ambulatory bone marrow transplant model. Canc. Pract. 8 (3),
120–128. https://doi.org/10.1046/j.1523-5394.2000.83005.x.
for assistance – are often overlooked (Ussher et al., 2009). Given the Grunfeld, E.A., Maher, E.J., Browne, S., Ward, P., Young, T., Vivat, B., Walker, G.,
dynamic nature of carers’ experiences, this study suggests that their Wilson, C., Potts, H.W., Westcombe, A.M., Richards, M., Ramirez, A.J., 2006.
needs should be assessed periodically. Advanced breast cancer patients’ perceptions of decision making for palliative
chemotherapy. J. Clin. Oncol. 24 (7), 1090–1098. https://doi.org/10.1200/
Finally, as indicated in previous research focusing on cancer carers’ JCO.2005.01.9208.
needs (Ream et al., 2013), this study points to the need for carer in­ Hennink, M.M., Kaiser, B.N., Marconi, V.C., 2017. Code saturation versus meaning
terventions that prepare carers for, and sustain them during, caregiving. saturation: how many interviews are enough? Qual. Health Res. 27 (4), 591–608.
Hodges, L.J., Humphris, G.M., 2009. Fear of recurrence and psychological distress in
Such interventions need to be pragmatic and feasible to deliver in what
head and neck cancer patients and their carers. Psycho Oncol. 18 (8), 841–848.
is effectively a clinical busy setting. One intervention – Take Care® – Hofman, M., Morrow, G.R., Roscoe, J.A., Hickok, J.T., Mustian, K.M., Moore, D.F.,
reported in the literature outlines the potential of a brief educative Ware, J.l., Fitch, T.R., 2004. Cancer patients’ expectations of experiencing
intervention for enhancing carers’ self-efficacy for caregiving during treatment-related side effects. Cancer 101 (4), 851–857. https://doi.org/10.1002/
cncr.20423.
chemotherapy (Tsianakas et al., 2015). It is the only intervention written Jenewein, J., Zwahlen, R., Zwahlen, D., Drabe, N., Moergeli, H., Büchi, S., 2008. Quality
about in the literature developed specifically for supporting cancer of life and dyadic adjustment in oral cancer patients and their female partners. Eur.
carers during this time. This is clearly an area that needs greater research J. Canc. Care 17 (2), 127–135. https://doi.org/10.1111/j.1365-2354.2007.00817.x.
Kent, E., Mollica, M., Buckenmaier, S., Wilder Smith, A., 2019. The characteristics of
and development in future. informal cancer caregivers in the United States. Semin. Oncol. Nurs. 35 (4),
328–332. https://doi.org/10.1016/j.soncn.2019.06.002.
Author contribution Lambert, S.D., McElduff, P., Girgis, A., Levesque, J.V., Regan, T.W., Turner, J.,
McElduff, P., Kayser, K., Vallentine, P., 2016. A pilot, multisite, randomized
controlled trial of a self-directed coping skills training intervention for couples facing
Emma Ream, Conceptualization, Methodology, Funding acquisition, prostate cancer: accrual, retention, and data collection issues. Support. Care Canc. 24
Data analysis, Writing draft, Reviewing & Editing, Alison Richardson: (2), 711–722. https://doi.org/10.1007/s00520-015-2833-3.
Macmillan Cancer Support, 2016. Under Pressure: the Growing Strain on Cancer Carers.
Conceptualization, Methodology, Reviewing & Editing, Grace Lucas: Retrieved from, London. https://www.macmillan.org.uk/documents/campaigns/un
Data analysis, Writing draft, Reviewing & Editing. Afrodita Marcu: Data der-pressure-the-growing-strain-on-cancer-carers-macmillan-cancer-support-septem
analysis, Writing draft, Reviewing & Editing. Jennifer Finnegan-John: ber-2016.pdf.
Matthews, B., Baker, F., Spillers, R., 2003. Family caregivers and indicators of cancer-
Data collection, Data analysis, Reviewing & Editing. Rebecca Foster: related distress. Psychol. Health Med. 8 (1), 46–56. https://doi.org/10.1080/
Data collection, Data analysis, Reviewing & Editing. Ginny Fuller: 1354850021000059250.
Funding acquisition, Conceptualization, Methodology, Reviewing & May, C., Montori, V.M., Mair, F.S., 2009. We need minimally disruptive medicine. Br
Med J 339, b2803.
Editing, Catherine Oakley: Methodology, Reviewing & Editing. McIlfatrick, S., Sullivan, K., McKenna, H., 2006. What about the carers?: exploring the
experience of caregivers in a chemotherapy day hospital setting. Eur. J. Oncol. Nurs.
10 (4), 294–303.
Declaration of competing interest McKenzie, H., White, K., Hayes, L., Fitzpatrick, S., Cox, K., River, J., 2017. ‘Shadowing’as
a management strategy for chemotherapy outpatient primary support persons.
The authors have no conflicts of interest to declare. Scand. J. Caring Sci. 31 (4), 887–894. https://doi.org/10.1111/scs.12410.
Murray, S.A., Kendall, M., Boyd, K., Grant, L., Highet, G., Sheikh, A., 2010. Archetypal
trajectories of social, psychological, and spiritual wellbeing and distress in family
Acknowledgements care givers of patients with lung cancer: secondary analysis of serial qualitative
interviews. Br Med J 340, c2581. https://doi.org/10.1136/bmj.c2581.
NCEPOD, 2008. For Better, for Worse? A Review of the Care of Patients Who Died within
This research was made possible through a grant from Macmillan 30 Days of Receiving Systemic Anti-cancer Therapy. Retrieved from London. htt
Cancer Support, UK and the generosity of the informal carers who gave p://www.ncepod.org.uk/2008report3/Downloads/SACT_report.pdf.
their time so their stories and experiences could be captured. We would Neville-Webbe, H., Carser, J., Wong, H., Andrews, J., Poulter, T., Smith, R., Marshall, E.,
2013. The impact of a new acute oncology service in acute hospitals: experience
also like to acknowledge the support of nurses in the day units where this from the Clatterbridge Cancer Centre and Merseyside and Cheshire Cancer Network.
research was conducted and thank them for their much valued assis­ Clin. Med. 13 (6), 565–569.
tance with recruitment. Without their support this research would not Norton, S., Wittink, M., Duberstein, P., Prigerson, H., Stanek, S., Epstein, R., 2019.
Family caregiver descriptions of stopping chemotherapy and end-of-life transitions.
have been possible.
Support. Care Canc. 27 (2), 669–675. https://doi.org/10.1007/s00520-018-4365-0.
Ream, E., Pedersen, V., Oakley, C., Richardson, A., Taylor, C., Verity, R., 2013. Informal
References carers’ experiences and needs when supporting patients through chemotherapy: a
mixed method study. Eur. J. Canc. Care 22 (6), 797–806. https://doi.org/10.1111/
ecc.12083.
Applebaum, A.J., Breitbart, W., 2013. Care for the cancer caregiver: a systematic review.
Renovanz, M., Maurer, D., Lahr, H., Weimann, E., Deininger, M., Wirtz, C.R., Ringel, F.,
Palliat. Support Care 11 (3), 231–252. https://doi.org/10.1017/
Singer, S., Coburger, J., 2018. Supportive care needs in glioma patients and their
S1478951512000594.
caregivers in clinical practice: results of a multicenter cross-sectional study. Front.
Aranda, S.K., Hayman-White, K., 2001. Home caregivers of the person with advanced
Neurol. 9 (763) https://doi.org/10.3389/fneur.2018.00763.
cancer: an Australian perspective. Canc. Nurs. 24 (4), 300–307.
Ritchie, J., Lewis, J., 2003. Qualitative Research Practice. A Guide for Social Science
Armes, J., Crowe, M., Colbourne, L., Morgan, H., Murrells, T., Oakley, C., Palmer, N.,
Students and Researchers. Sage Publications, London.
Ream, E., Young, A., Richardson, A., 2009. Patients’ supportive care needs beyond
Roberts, D., Calman, L., Large, P., Appleton, L., Grande, G., Lloyd-Williams, M.,
the end of cancer treatment: a prospective, longitudinal survey. J. Clin. Oncol. 27
Walshe, C., 2018. A revised model for coping with advanced cancer. Mapping
(36), 6172–6179. https://doi.org/10.1200/JCO.2009.22.5151.
concepts from a longitudinal qualitative study of patients and carers coping with
Bell, K., 2009. ‘If it almost kills you that means it’s working!’Cultural models of
advanced cancer onto Folkman and Greer’s theoretical model of appraisal and
chemotherapy expressed in a cancer support group. Soc. Sci. Med. 68 (1), 169–176.
coping. Psycho Oncol. 27 (1), 229–235.
https://doi.org/10.1016/j.socscimed.2008.10.023.
Round, J., Jones, L., Morris, S., 2015. Estimating the cost of caring for people with cancer
Calman, L., Brunton, L., Molassiotis, A., 2013. Developing longitudinal qualitative
at the end of life: a modelling study. Palliat. Med. 29 (10), 899–907.
designs: lessons learned and recommendations for health services research. BMC
Med. Res. Methodol. 13 (1), 14.

9
E. Ream et al. European Journal of Oncology Nursing 50 (2021) 101861

Saldaña, J., 2003. Longitudinal Qualitative Research: Analysing Change through Time. feasibility of a complex intervention co-designed by carers and staff. Support. Care
Alta Mira Press, Walnut Creek, California. Canc. 23 (10), 3069–3080.
Schmer, C., Ward-Smith, P., Latham, S., Salacz, M., 2008. When a family member has a Ullgren, H., Tsitsi, T., Papastavrou, E., Charalambous, A., 2018. How family caregivers of
malignant brain tumor: the caregiver perspective. J. Neurosci. Nurs. 40 (2), 78–84. cancer patients manage symptoms at home: a systematic review. Int. J. Nurs. Stud.
Sklenarova, H., Krümpelmann, A., Haun, M.W., Friederich, H.C., Huber, J., Thomas, M., 85, 68–79. https://doi.org/10.1016/j.ijnurstu.2018.05.004.
Winkler, E.C., Herzog, W., Hartmann, M., 2015. When do we need to care about the Ussher, J.M., Perz, J., Hawkins, Y., Brack, M., 2009. Evaluating the efficacy of psycho-
caregiver? Supportive care needs, anxiety, and depression among informal social interventions for informal carers of cancer patients: a systematic review of the
caregivers of patients with cancer and cancer survivors. Cancer 121 (9), 1513–1519. research literature. Health Psychol. Rev. 3 (1), 85–107. https://doi.org/10.1080/
https://doi.org/10.1002/cncr.29223. 17437190903033401.
Taylor, A., Wells, M., Hubbard, G., Worth, A., 2016. From an illusion of certainty into a Walshe, C., Roberts, D., Appleton, L., Calman, L., Large, P., Lloyd-Williams, M.,
reality of uncertainty: a longitudinal qualitative study of how people affected by Grande, G., 2017. Coping well with advanced cancer: a serial qualitative interview
laryngeal cancer use information over time. Eur. J. Oncol. Nurs. 23, 15–23. study with patients and family carers. PloS One 12 (1), e0169071.
Tsianakas, V., Robert, G., Richardson, A., Verity, R., Oakley, C., Murrells, T., Flynn, M., Williams, A.-l., Tisch, A.J.H., Dixon, J., McCorkle, R., 2013. Factors associated with
Ream, E., 2015. Enhancing the experience of carers in the chemotherapy outpatient depressive symptoms in cancer family caregivers of patients receiving
setting: an exploratory randomised controlled trial to test impact, acceptability and chemotherapy. Support. Care Canc. 21 (9), 2387–2394.

10